MYC and chronic myelogenous leukemia, BCR-ABL1 positive: Importantly, c-Myc reduction represents a key step for Imatinib induced cell death in CML; indeed, elevated c-Myc levels are found during CML blast crisis phase and correlate with poor response to Imatinib [11–13].